Bristol-Myers Squibb Company (BMY) support and resistance · P/E 17, rev $24.46B
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
This page maps Bristol-Myers Squibb Company (BMY) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new BMY 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the BMY quote page for the session range and the stock page for the full model.
Not investment advice.